These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 29866361)

  • 21. HBV cure: why, how, when?
    Levrero M; Testoni B; Zoulim F
    Curr Opin Virol; 2016 Jun; 18():135-43. PubMed ID: 27447092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Control and Eradication Strategies of Hepatitis B Virus.
    Shih C; Chou SF; Yang CC; Huang JY; Choijilsuren G; Jhou RS
    Trends Microbiol; 2016 Sep; 24(9):739-749. PubMed ID: 27287929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A hepatitis B-free generation in China: from dream to reality.
    Fan R; Yin X; Liu Z; Liu Z; Lau G; Hou J
    Lancet Infect Dis; 2016 Oct; 16(10):1103-1105. PubMed ID: 27676339
    [No Abstract]   [Full Text] [Related]  

  • 24. Recent advances in hepatitis B virus research: a German point of view.
    Glebe D
    World J Gastroenterol; 2007 Jan; 13(1):8-13. PubMed ID: 17206750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel treatment options for hepatitis B virus infection.
    Kumar R; Agrawal B
    Curr Opin Investig Drugs; 2004 Feb; 5(2):171-8. PubMed ID: 15043391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current therapeutic approaches for HBV infected patients.
    Gill US; Kennedy PTF
    J Hepatol; 2017 Aug; 67(2):412-414. PubMed ID: 28629790
    [No Abstract]   [Full Text] [Related]  

  • 27. Bacteriophages and their applications in the diagnosis and treatment of hepatitis B virus infection.
    Bakhshinejad B; Sadeghizadeh M
    World J Gastroenterol; 2014 Sep; 20(33):11671-83. PubMed ID: 25206272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [New antivirals for hepatitis B virus infection].
    Nakamoto S; Kanda T; Yokosuka O
    Nihon Rinsho; 2015 Dec; 73 Suppl 9():540-5. PubMed ID: 26845993
    [No Abstract]   [Full Text] [Related]  

  • 29. Impact of integrated viral DNA on the goal to clear hepatitis B surface antigen with different therapeutic strategies.
    Lindh M; Rydell GE; Larsson SB
    Curr Opin Virol; 2018 Jun; 30():24-31. PubMed ID: 29453099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of hepatitis B virus populations in an interferon-alpha-treated patient reveals predominant mutations in the C-gene and changing e-antigenicity.
    Günther S; Paulij W; Meisel H; Will H
    Virology; 1998 Apr; 244(1):146-60. PubMed ID: 9581787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel viral and host targets to cure hepatitis B.
    Ko C; Michler T; Protzer U
    Curr Opin Virol; 2017 Jun; 24():38-45. PubMed ID: 28433762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Advance in clinical studies of the kinetics of hepatitis B virus].
    Tang YT; Cao Q; Zhang DZ
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jan; 18(1):75-7. PubMed ID: 20128981
    [No Abstract]   [Full Text] [Related]  

  • 33. Recent advance of the hepatitis B virus inhibitors: a medicinal chemistry overview.
    Jia H; Rai D; Zhan P; Chen X; Jiang X; Liu X
    Future Med Chem; 2015; 7(5):587-607. PubMed ID: 25921400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High incidence of treatment-induced and vaccine-escape hepatitis B virus mutants among human immunodeficiency virus/hepatitis B-infected patients.
    Lacombe K; Boyd A; Lavocat F; Pichoud C; Gozlan J; Miailhes P; Lascoux-Combe C; Vernet G; Girard PM; Zoulim F
    Hepatology; 2013 Sep; 58(3):912-22. PubMed ID: 23468093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Present and future DNA vaccines for chronic hepatitis B treatment.
    Cova L
    Expert Opin Biol Ther; 2017 Feb; 17(2):185-195. PubMed ID: 27892722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Future prevention and treatment of chronic hepatitis B infection.
    Seto WK; Fung J; Yuen MF; Lai CL
    J Clin Gastroenterol; 2012 Oct; 46(9):725-34. PubMed ID: 22914347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of telbivudine on infants born to HBsAg-positive mothers with non-/hypo-response to hepatitis B vaccine during their second and third trimesters of pregnancy].
    Xu XX; Wang B; Wang XF; Wen HX; Zhang F; Yang ZQ; Hao HY; Wang T; Shi XH; Fu ZD; Wang B; Wang SP
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Feb; 38(2):168-172. PubMed ID: 28231660
    [No Abstract]   [Full Text] [Related]  

  • 38. Understanding the Complex Patterns Observed during Hepatitis B Virus Therapy.
    Carracedo Rodriguez A; Chung M; Ciupe SM
    Viruses; 2017 May; 9(5):. PubMed ID: 28534812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Getting to zero mother-to-child transmission of hepatitis B virus: dream and challenge].
    Yin XR; Liu ZH; Liu ZH; Li J; Zhuang H; Dou XG; Hou JL
    Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):262-265. PubMed ID: 29996336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overview: past and future of immunologic intervention in the pathogenesis, prophylaxis and therapeusis of hepatitis B.
    Hilleman MR
    J Gastroenterol Hepatol; 2002 Dec; 17 Suppl():S449-51. PubMed ID: 12534776
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.